Investigating Atezolizumab in Newly Diagnosed ER Positive Breast Cancer Patients According to Their AdipOsity
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Letrozole|DRUG: Atezolizumab
Sponsor: Universitaire Ziekenhuizen KU Leuven
Collaborators: KU Leuven